Effectiveness of Motivational Interview in Patients With Dyslipidemia

Patients With Dyslipidemia Clinical Trial

— Dislip-EM  

Official title:

Effectiveness of Motivational Interview in Patients With Dyslipidemia Treated in Primary Care Consultations (Dislip-EM Study)

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01282190
• Other study ID #: PI-0100/2008
• Status: Completed
• Phase: N/A
• First received: January 21, 2011
• Last updated: August 17, 2015
• Start date: June 2010
• Est. completion date: March 2015

Study information

• Verified date: August 2015
• Source: Hospital Universitario Reina Sofia
• Contact: n/a
• Is FDA regulated: No
• Health authority: Spain: Autonomic Committee of Clinical Trials (Andalusian)
• Study type: Interventional

Clinical Trial Summary

Evaluate the effectiveness of motivational interviewing to improve lipid control and cardiovascular risk in patients with dyslipidemia.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 207
• Est. completion date: March 2015
• Est. primary completion date: March 2015
• Accepts healthy volunteers: Accepts Healthy Volunteers
• Gender: Both
• Age group: 40 Years to 75 Years

Eligibility

Inclusion Criteria:

• People diagnosed with dyslipidemia

• To sign informed consent.

Exclusion Criteria:

• Secondary hypercholesterolemia.

• Familial hypercholesterolemia.

• Deficiency syndromes family high density lipoprotein.

• Subjects with a history of cardiac or cerebrovascular events.

• Other chronic health problems such as diabetes or severe COPD.

• Subjects with current diagnosis of cancer.

• Patients with hepatic or renal disorders .

• Subjects heavy drinkers.

• Patients with long standing sick leave (more than 6 months).

• Pregnant or breastfeeding.

Study Design

Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Prevention

Related Conditions & MeSH terms

• Dyslipidemias
• Patients With Dyslipidemia

Intervention

Behavioral:
• Motivational interview
Motivational interview

Locations

Country	Name	City	State
Spain	Family Medicine Teaching Unit and Community	Córdoba

Sponsors (2)

Lead Sponsor	Collaborator
Hospital Universitario Reina Sofia	Spanish Society of Family and Community Medicine

Country where clinical trial is conducted

Spain, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	lipid levels		12 months	Yes
Secondary	cardiovascular risk		12 months	Yes

External Links

•   protocol study